• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶原酶组装和S1位点占据可恢复因钠结合位点突变而受损的FXa的催化活性。

Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site.

作者信息

Camire Rodney M

机构信息

Joseph Stokes, Jr. Research Institute, Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.

出版信息

J Biol Chem. 2002 Oct 4;277(40):37863-70. doi: 10.1074/jbc.M203692200. Epub 2002 Jul 30.

DOI:10.1074/jbc.M203692200
PMID:12149252
Abstract

Two loop segments (183-189 and 221-225) in the protease domain of factor Xa contribute to the formation of a Na(+)-binding site. Studies with factor Xa indicate that binding of a single Na(+) ion to this site influences its activity by altering the S1 specificity site, and substitution of Tyr(225) with Pro diminishes sensitivity to Na(+). Using full-length factor Xa(Y225P), the allosteric relationship between the Na(+) site and other structural determinants in factor Xa and prothrombinase was investigated. Direct binding and kinetic measurements with probes that target the S1 specificity pocket indicate that assembly of the mutant in prothrombinase corrected the impaired binding of these probes observed with free factor Xa(Y225P). This appears to result from the apparent allosteric linkage between the factor Va, S1, and Na(+)-binding sites, since binding of the cofactor to membrane-bound factor Xa(Y225P) enhances binding at the S1 site and vice versa. Additional studies revealed that the internal salt bridge (Ile(16)-Asp(194)) of factor Xa(Y225P) is partially destabilized, a process that is reversible upon occupation of the S1 site. The data establish that alterations at the factor Xa Na(+)-binding site shift the zymogen-protease equilibrium to a more zymogen-like state, and as a consequence binding of S1-directed probes and factor Va are adversely affected. Therefore, the zymogen-like characteristics of factor Xa(Y225P) have allowed for the apparent allosteric linkage between the S1, factor Va, and Na(+) sites to become evident and has provided insight into the structural transitions which accompany the conversion of factor X to factor Xa.

摘要

凝血因子Xa蛋白酶结构域中的两个环段(183 - 189和221 - 225)有助于形成一个钠离子结合位点。对凝血因子Xa的研究表明,单个钠离子与该位点的结合通过改变S1特异性位点来影响其活性,用脯氨酸取代酪氨酸(225)会降低对钠离子的敏感性。利用全长凝血因子Xa(Y225P),研究了凝血因子Xa和凝血酶原酶中钠离子位点与其他结构决定因素之间的变构关系。使用靶向S1特异性口袋的探针进行直接结合和动力学测量表明,凝血酶原酶中突变体的组装纠正了游离凝血因子Xa(Y225P)中观察到的这些探针结合受损的情况。这似乎是由于辅因子Va、S1和钠离子结合位点之间明显的变构联系,因为辅因子与膜结合的凝血因子Xa(Y225P)的结合增强了S1位点的结合,反之亦然。进一步的研究表明,凝血因子Xa(Y225P)的内部盐桥(异亮氨酸(16)-天冬氨酸(194))部分不稳定,该过程在S1位点被占据后是可逆的。数据表明,凝血因子Xa钠离子结合位点的改变将酶原 - 蛋白酶平衡转变为更类似酶原的状态,结果是S1导向探针和辅因子Va的结合受到不利影响。因此,凝血因子Xa(Y225P)的酶原样特征使得S1、辅因子Va和钠离子位点之间明显的变构联系变得明显,并为凝血因子X向凝血因子Xa转化过程中伴随的结构转变提供了见解。

相似文献

1
Prothrombinase assembly and S1 site occupation restore the catalytic activity of FXa impaired by mutation at the sodium-binding site.凝血酶原酶组装和S1位点占据可恢复因钠结合位点突变而受损的FXa的催化活性。
J Biol Chem. 2002 Oct 4;277(40):37863-70. doi: 10.1074/jbc.M203692200. Epub 2002 Jul 30.
2
Sodium binding site of factor Xa: role of sodium in the prothrombinase complex.凝血因子Xa的钠结合位点:钠在凝血酶原酶复合物中的作用。
Biochemistry. 2000 Feb 22;39(7):1817-25. doi: 10.1021/bi992006a.
3
Role of the alpha-helix 163-170 in factor Xa catalytic activity.α-螺旋163-170在凝血因子Xa催化活性中的作用。
J Biol Chem. 2007 Oct 26;282(43):31569-79. doi: 10.1074/jbc.M704837200. Epub 2007 Aug 28.
4
The critical role of the 185-189-loop in the factor Xa interaction with Na+ and factor Va in the prothrombinase complex.凝血酶原酶复合物中185 - 189环在凝血因子Xa与Na⁺及凝血因子Va相互作用中的关键作用。
J Biol Chem. 2004 Nov 12;279(46):48262-9. doi: 10.1074/jbc.M409964200. Epub 2004 Sep 3.
5
Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human coagulation factor xa. Studies on catalytic efficiency and inhibitor binding.人凝血因子Xa蛋白酶结构域中S1位点、Na⁺位点和Ca²⁺位点之间的热力学联系。催化效率及抑制剂结合研究。
J Biol Chem. 2000 Nov 24;275(47):36876-84. doi: 10.1074/jbc.M001386200.
6
Functional mapping of charged residues of the 82-116 sequence in factor Xa: evidence that lysine 96 is a factor Va independent recognition site for prothrombin in the prothrombinase complex.凝血因子Xa中82 - 116序列带电残基的功能图谱:赖氨酸96是凝血酶原酶复合物中凝血酶原的一个不依赖于因子Va的识别位点的证据。
Biochemistry. 2005 Aug 2;44(30):10063-70. doi: 10.1021/bi0508791.
7
Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.凝血因子Va上靠近精氨酸506激活蛋白C裂解位点的凝血因子Xa结合位点的特征分析。
J Biol Chem. 2007 Jul 27;282(30):21848-55. doi: 10.1074/jbc.M702192200. Epub 2007 Jun 6.
8
Directed glycosylation of human coagulation factor X at residue 333. Insight into factor Va-dependent prothrombin catalysis.人凝血因子X在333位残基处的定向糖基化。对因子Va依赖性凝血酶原催化作用的深入了解。
J Biol Chem. 2000 Dec 8;275(49):38774-9. doi: 10.1074/jbc.M004573200.
9
Amino acids Glu323, Tyr324, Glu330, and Val331 of factor Va heavy chain are essential for expression of cofactor activity.凝血因子Va重链的氨基酸Glu323、Tyr324、Glu330和Val331对于辅因子活性的表达至关重要。
J Biol Chem. 2003 Jul 25;278(30):28335-45. doi: 10.1074/jbc.M300233200. Epub 2003 May 8.
10
Factor Va alters the conformation of the Na+-binding loop of factor Xa in the prothrombinase complex.因子Va改变凝血酶原酶复合物中因子Xa的钠离子结合环构象。
Biochemistry. 2008 Jun 3;47(22):5976-85. doi: 10.1021/bi800319r. Epub 2008 May 6.

引用本文的文献

1
Basic regions of factor V and tissue factor pathway inhibitor mediate heavy chain and acidic region interactions on factor V revealed by tethered chemical cleavage.通过连接化学切割揭示的凝血因子V和组织因子途径抑制剂的基本区域介导凝血因子V重链与酸性区域的相互作用。
J Thromb Haemost. 2025 Aug;23(8):2449-2460. doi: 10.1016/j.jtha.2025.04.028. Epub 2025 May 12.
2
Unexpected Dynamic Binding May Rescue the Binding Affinity of Rivaroxaban in a Mutant of Coagulation Factor X.意外的动态结合可能挽救利伐沙班在凝血因子X突变体中的结合亲和力。
Front Mol Biosci. 2022 May 5;9:877170. doi: 10.3389/fmolb.2022.877170. eCollection 2022.
3
Structure of human factor VIIa-soluble tissue factor with calcium, magnesium and rubidium.
人因子 VIIa-可溶性组织因子与钙、镁和铷的结构。
Acta Crystallogr D Struct Biol. 2021 Jun 1;77(Pt 6):809-819. doi: 10.1107/S2059798321003922. Epub 2021 May 14.
4
Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.TFPIα 对因子 V 和因子 V 短片段的调节:B 结构域蛋白水解与结合的关系。
J Biol Chem. 2021 Jan-Jun;296:100234. doi: 10.1074/jbc.RA120.016341. Epub 2021 Jan 7.
5
Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study.人凝血因子 IXa 丝氨酸蛋白酶结构域中的钠离子结合位点:来自晶体结构和分子动力学模拟研究的证据。
J Thromb Haemost. 2019 Apr;17(4):574-584. doi: 10.1111/jth.14401. Epub 2019 Mar 6.
6
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors.工程化因子 Xa 变体在不依赖直接因子 Xa 抑制剂的情况下保留促凝血活性。
Nat Commun. 2017 Sep 13;8(1):528. doi: 10.1038/s41467-017-00647-9.
7
Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex.溶血硫苷脂结合凝血因子Xa并抑制凝血酶原酶复合物产生凝血酶。
PLoS One. 2015 Aug 11;10(8):e0135025. doi: 10.1371/journal.pone.0135025. eCollection 2015.
8
Hemostatic agents of broad applicability produced by selective tuning of factor Xa zymogenicity.通过对Xa因子酶原性进行选择性调节产生的具有广泛适用性的止血剂。
Blood. 2015 Jul 2;126(1):94-102. doi: 10.1182/blood-2015-03-634329. Epub 2015 Apr 20.
9
Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.一名凝血因子X基因中缺少天冬氨酸-185密码子的出血患者凝血缺陷的分子基础。
Thromb Res. 2014 Nov;134(5):1103-9. doi: 10.1016/j.thromres.2014.08.004. Epub 2014 Aug 20.
10
New insights into the spatiotemporal localization of prothrombinase in vivo.体内凝血酶原酶时空定位的新见解。
Blood. 2014 Sep 11;124(11):1705-14. doi: 10.1182/blood-2014-03-565010. Epub 2014 May 28.